Cargando…

Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers

Activated hepatic stellate cells (aHSCs) are the main orchestrators of the fibrotic cascade in inflamed livers, with transforming growth factor-beta (TGF-β) being the most potent pro-fibrotic cytokine. Hence, aHSCs serve as interesting therapeutic targets. However, drug delivery to aHSCs is hindered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azzam, Menna, El Safy, Sara, Abdelgelil, Sarah A., Weiskirchen, Ralf, Asimakopoulou, Anastasia, de Lorenzi, Federica, Lammers, Twan, Mansour, Samar, Tammam, Salma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356502/ https://www.ncbi.nlm.nih.gov/pubmed/32630415 http://dx.doi.org/10.3390/pharmaceutics12060590

Ejemplares similares

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis
por: Min, Kyounghee, et al.
Publicado: (2023)

Peptide-Based siRNA Nanocomplexes Targeting Hepatic Stellate Cells
por: Lin, Chien-Yu, et al.
Publicado: (2023)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Chitosan and Its Structural Modifications for siRNA Delivery
por: Al-Absi, Mona Y., et al.
Publicado: (2023)

Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
por: Lin, Zesi, et al.
Publicado: (2015)

Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
por: Asimakopoulou, Anastasia, et al.
Publicado: (2016)

Chitosan Hydrogel as siRNA vector for prolonged gene silencing
por: Ma, Zhiwei, et al.
Publicado: (2014)

Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
por: Weiskirchen, Ralf
Publicado: (2016)

Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?
por: Herrmann, Jens, et al.
Publicado: (2007)

Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2
por: Tammam, Salma N., et al.
Publicado: (2021)

Novel Ellipsoid Chitosan-Phthalate Lecithin Nanoparticles for siRNA Delivery
por: Saeed, Ramzi Mukred, et al.
Publicado: (2021)

PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells
por: Rady, Brian, et al.
Publicado: (2021)

Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells
por: Lee, Hae Lim, et al.
Publicado: (2022)

Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation
por: Cierpka, Rafael, et al.
Publicado: (2021)

Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Effects of Chain Length of Chitosan Oligosaccharides on Solution Properties and Complexation with siRNA
por: Delas, Tim, et al.
Publicado: (2019)

Chitosan Oleate Coated PLGA Nanoparticles as siRNA Drug Delivery System
por: Miele, Dalila, et al.
Publicado: (2021)

Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy
por: Thomes, Paul G., et al.
Publicado: (2016)

Hsp70 Knockdown by siRNA Decreased Collagen Production in Keloid Fibroblasts
por: Shin, Jung U, et al.
Publicado: (2015)

The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
por: Weiskirchen, Ralf, et al.
Publicado: (2015)

Development of Chitosan Nanoparticles as a Stable Drug Delivery System for Protein/siRNA
por: Katas, Haliza, et al.
Publicado: (2013)

Potential application of injectable chitosan hydrogel treated with siRNA in chronic rhinosinusitis therapy
por: CAO, CHENG, et al.
Publicado: (2015)

Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA
por: Capel, Victoria, et al.
Publicado: (2018)

Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives
por: Serrano-Sevilla, Inés, et al.
Publicado: (2019)

Chitosan-Based Glycolipid Conjugated siRNA Delivery System for Improving Radiosensitivity of Laryngocarcinoma
por: Miao, Jing, et al.
Publicado: (2021)

Designing siRNA/chitosan-methacrylate complex nanolipogel for prolonged gene silencing effects
por: Cao, Ye, et al.
Publicado: (2022)

In Vitro Cellular Uptake and Transfection of Oligoarginine-Conjugated Glycol Chitosan/siRNA Nanoparticles
por: Jeong, Eun-Ju, et al.
Publicado: (2021)

Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012)

Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells
por: Koenen, Maria Teresa, et al.
Publicado: (2022)

Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling
por: Horn, Margaux A., et al.
Publicado: (2016)

Assessment of the epi-pericardial fibrotic substrate by collagen-targeted probes
por: Ezeani, Martin, et al.
Publicado: (2022)

Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies
por: Fernandes, Julio C, et al.
Publicado: (2012)

Safety and toxicology of the intravenous administration of Ang2-siRNA plasmid chitosan magnetic nanoparticles
por: Shan, Xiuying, et al.
Publicado: (2017)

Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing
por: Shaabani, Elnaz, et al.
Publicado: (2021)

HDL-Chitosan Nanoparticles for siRNA Delivery as an SR-B1 Receptor Targeted System
por: Masimov, Rasim, et al.
Publicado: (2023)

Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
por: Hicks, Daniel F., et al.
Publicado: (2017)

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
por: Lee, Young-Sun, et al.
Publicado: (2017)

Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro
por: Hübbers, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rml59s9ssci183n22nck7gje0t